Viking Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-47.6M | $-47.6M | — | $6.1M |
| FY2022 | $-48.4M | $-48.4M | — | $8.7M |
| FY2023 | $-73.4M | $-73.4M | — | $16.8M |
| FY2024 | $-87.8M | $-87.8M | — | $29.7M |
| FY2025 | $-278.7M | $-278.7M | — | $40.8M |